Posts

Roche sees receding biosimilar impact, but Vabysmo slump returns

on

Samsung launches AI-powered Health Assistant to decode health data

on

Henlius to Showcase 12 Research Presentations at ESMO 2026, Including U.S. Bridging Study of Serplulimab and PoC of PD-L1 ADC HLX43 in Gastric Cancer (Summary Highlights)

on

U.S. Biotechs Go Dark as China's Biotech Rise Sparks Paranoia

on

U.S. Launches Section 301 Investigation into Germany Over Drug Pricing and Unfair R&D Burden in 2026

on

Oncolytics Biotech Secures New U.S. Patent Protecting Commercial Manufacturing of Pelareorep into 2044

on

Lupin Receives U.S. FDA Approval for Ranluspec™ (ranibizumab) Injection: Interchangeable Biosimilar for Eye Diseases Now Cleared in the U.S.

on

SKIA HEAD Gains FDA Clearance for AR Surgical Guidance

on

Brand‑name drug prices keep climbing in the U.S. while falling abroad, amid push for MFN pricing: Report highlights

on

Post-Hoc Live: Jeremy Levin warns of threats to U.S. biotech

on

Takeda faces possible $2.5 billion damages in Amitiza pay‑for‑delay case

on

Drugmakers must disclose U.S. production plans to qualify for tariff exemptions

on

"We need to put some bad ideas to bed": Inside Incubate's battles for biotech on Capitol Hill

on

UK Agrees to Increase Drug Spending by 25% to Avoid US Pharma Tariffs

on

Kane Biotech Announces Third Quarter 2025 Financial Results

on

Ypsomed Invests $248 Million to Establish First U.S. Manufacturing Site in North Carolina

on

FDA Launches Pilot Program to Prioritize U.S. Generic Drug Manufacturing and Testing

on

Vaxcyte Strikes up to $1B Fill-Finish Manufacturing Deal with Thermo Fisher at North Carolina Facility

on

Sanofi Expands $35 Insulin Program to All U.S. Patients Nationwide

on

GSK Commits $30 Billion to Bolster U.S. R&D and Manufacturing

on